Status:
SUSPENDED
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program
Lead Sponsor:
Emory University
Conditions:
Clostridium Difficile Infection
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to rapidly identify subjects who are eligible for the Microbiota Enrichment Program (MEP) at Emory in Atlanta, Georgia. This general screening protocol will be used to screen...
Detailed Description
The unintended consequence of the development of life-saving antimicrobial therapies has been the havoc that is wreaked on the patient's intestinal microbiota. Clostridium difficile infection (CDI) ha...
Eligibility Criteria
Inclusion
- Age of at least 18 years
- Seeking services that are affiliated with the Emory Microbiota Enrichment Program (MEP) for any reason, such as:
- Clinical services, interventions, or procedures (e.g., FMT), or
- Research studies
- Able to understand and approve the informed consent and HIPAA authorizations forms verbally on the phone or by signature in-person
Exclusion
- Known or suspected terminal disease
Key Trial Info
Start Date :
September 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03350711
Start Date
September 13 2018
End Date
January 1 2028
Last Update
May 22 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Clinic
Atlanta, Georgia, United States, 30322
2
Emory Hospital
Atlanta, Georgia, United States, 30322
3
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, United States, 30030